Primary Site >> Biliary tract Cancer
Gene >> SOX9
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. PMID: 21931375 |
Ref: Constitutive Notch2 signaling induces hepatic tumors in mice. PMID: 23175466 |
Ref: IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism. PMID: 25580681 Ref: Novel surface markers directed against adult human gallbladder. PMID: 26079872 Ref: Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma. PMID: 26341967 |
Ref: Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma. PMID: 27280413 |
Ref: Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". PMID: 28232156 |
Ref: Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy. PMID: 29452147 Ref: Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. PMID: 29545603 Ref: Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma. PMID: 29871934 |